Ignite Creation Date:
2025-12-25 @ 12:28 AM
Ignite Modification Date:
2026-07-06 @ 2:02 AM
Study NCT ID:
NCT01992367
Status:
COMPLETED
Last Update Posted:
2016-11-02
First Post:
2013-11-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1, Randomised Double Blinded Placebo Controlled Study of ASLAN003
Sponsor:
ASLAN Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy Volunteers | View |
Keywords: